Infusion device with needle shield

Information

  • Patent Grant
  • 7147623
  • Patent Number
    7,147,623
  • Date Filed
    Tuesday, February 11, 2003
    21 years ago
  • Date Issued
    Tuesday, December 12, 2006
    17 years ago
Abstract
The invention relates to a medication infusion set of the type having a flexible cannula adapted for subcutaneous placement, in combination with an insertion, or puncturing, device comprising an insertion needle extending through the cannula and beyond the outer tip thereof, the insertion device further comprising a shield adapted to cover the insertion needle when the latter is withdrawn from the cannula. More specifically, the invention provides a fully integrated shield member having a position in which it covers the cannula and the needle when the insertion device is connected to the housing, a position allowing the cannula to be inserted when the insertion device is connected to the housing, and a position in which the shield covers the needle and the outer tip thereof when the insertion device has been removed from the housing. By this arrangement the need for a separate cover to protect the needle prior to use can be dispensed with.
Description

This application claims priority to Danish Application PA 2002 00208, filed Feb. 12, 2002, the entirety of this reference is incorporated herein.


FIELD OF THE INVENTION

The invention relates generally to devices for delivering a selected medication or another therapeutic fluid to a patient at a subcutaneous or other infusion site. More particularly, the invention relates to a medication infusion set of the type having a flexible cannula adapted for subcutaneous placement, in combination with an insertion, or puncturing, device comprising an insertion needle extending through the cannula and beyond the outer tip thereof, the insertion device further comprising a shield adapted to cover the insertion needle when the latter is withdrawn from the cannula.


BACKGROUND OF THE INVENTION

Medication injection or infusion sets are generally well known in the art, to include a relatively soft and flexible cannula providing a transcutaneous pathway through which a selected medication or other therapeutic fluid can be administered to a patient at a selected subcutaneous site. In a common form, the soft cannula is carried by a housing initially assembled with an insertion needle extending through the cannula, wherein the insertion needle is manipulated to pierce the patient's skin to place the cannula transcutaneously, followed by withdrawal of the insertion needle to leave the soft cannula in place on the patient. In order to allow the insertion needle to be handled, the needle is normally provided as an insertion device comprising a hub to which the needle is attached.


The selected medication may then be coupled to the cannula, typically by means of a length of infusion tubing connected to a medication source to deliver the medication through the cannula to the patient.


In one configuration, the infusion tubing is connected to the cannula housing corresponding to the opening through which the insertion needle has been withdrawn from the cannula, i.e. the tubing is arranged axially with respect to the general axial orientation of the cannula. An example of this type of infusion device is disclosed in U.S. Pat. No. 6,056,718.


In a second configuration, the infusion tubing is connected to the cannula housing at a location different from the opening through which the insertion needle is inserted into the cannula, this configuration allowing the tubing to be pre-connected to the housing. An example of this type of infusion device is known from WO 00/03757 and U.S. Pat. No. 5,545,143 both disclosing a device in which the cannula and insertion needle are arranged perpendicular to tubing. In order to seal the device, a self-sealing penetratable septum is provided corresponding to the opening through which the insertion needle is withdrawn, this septum also allowing samples to be taken without having to disconnect the tubing.


The use of insertion needles, or needle devices in general, is associated with some disadvantages during use thereof due to the potential danger of exposure to the pointed tip before use as well as after the needle has been withdrawn and before it has been properly discarded. Correspondingly, a large number of needle protection devices have been proposed to provide a remedy to this problem.


A very simple form of protection is the traditional tubular sleeve which normally covers the needle when supplied to the user, for example as shown in U.S. Pat. No. 5,545,143; after use the cover may be used to cover the needle again, however, in most cases the needle and the cover are discarded separately A more elaborate shell-shaped needle guard is disclosed in U.S. Pat. No. 6.056,718, however, basically this guard functions as a simple needle cover to be removed from the insertion device prior to use.


In order to better protect against unintended needle prick, a number of shield devices has been proposed based on the principle that a pivotable shield is mounted corresponding to the front of the device, this allowing the shield to be pivoted away before use of the needle as well as used to cover the needle immediately after use, An example of this type of needle protection device is disclosed in U.S. Pat. No. 5,011,475.


For the above-described type of infusion devices in which an insertion needle is arranged through a cannula, different solutions have been proposed. For example, a recent type of needle protection devices is based upon the principle that a protecting means automatically grips the needle tip as the insertion needle is withdrawn from the infusion device, however, this solution requires a separate cover to protect the needle prior to use,


A different approach is known from WO 00/03757 disclosing an infusion device in which an insertion needle hub is provided with a hinged shield member protruding there from, whereby the shield member is adapted to pivot and thereby cover the insertion needle when withdrawn from the infusion device. Also this solution requires a separate cover to protect the needle prior to use.


SUMMARY OF THE INVENTION

Having regard to the above discussion of the prior art, the object of the present invention is to provide an infusion device comprising a hollow cannula and having an insertion needle arranged there through, in which shielding means is incorporated providing a user with a high degree of protection against injury from unintended needle prick during operation and handling of the device yet providing ease of use as well as allowing the device to be manufactured in a simple and cost effective manner.


The present invention is based on the realisation that an infusion device of the above type having an insertion needle arranged through a cannula can be provided with a fully integrated needle shield by forming the needle with an integrated shield which is capable of both covering the cannula with the needle inserted there through prior to use, as well as covering the needle when it is withdrawn from the cannula, yet allowing the user to insert the cannula More specifically, this functionality is achieved by providing a “bridge” between the hub portion of the insertion device and the shield actually covering the needle/cannula, this allowing the hitherto separately supplied components to be formed integrally with each other.


Thus, in accordance with the invention, an infusion set comprising an infusion device and an insertion (puncturing) device is provided, the infusion device having a housing comprising an opening and a soft cannula extending from the housing and being in flow communication with the opening, the soft cannula having an outer tip, an insertion device adapted to be connected to said housing, the insertion device comprising a hub and a needle mounted thereon the needle being adapted to extend through the cannula and beyond the outer tip thereof when the insertion device is connected to the housing, the needle being at the outer end adapted for facilitating puncturing, wherein a shield member is provided having an initial position in which it covers the cannula and the protruding outer tip of the needle, a retracted position allowing the cannula to be inserted, and a final position in which the shield covers the needle when the insertion device has been removed from the housing.


The final position may be identical with the initial position, or it may be different as in a preferred embodiment in which the needle is bend when the shield member and the hub is locked together, whereby the bend needle provides a biasing effect between cooperating locking means on the shield part and the handle part, and whereby the bend needle closely abuts on the shield to ensure that unintended contact with the needle is avoided.


In a preferred embodiment the shield member is in the form of a single cover member extending generally along the axis of the cannula/needle, and being pivotally connected to the hub allowing it to be pivoted between its different positions. The pivoting action may be provided by a “traditional” hinge or by any flexible arrangement allowing the shield member to pivot or deflect relative to the hub. The shield member may be arranged to pivot corresponding to any desired axis, e.g. parallelly with or perpendicular to the skin surface in a situation of use.


Preferably the different positions are predefined, the housing and/or insertion device comprising mating coupling means so as to allow the shield member to lock into its initial, its retracted respectively its final position. Indeed, the mating coupling means for the initial and for the retracted positions should be adapted for releasably securing the shield in the respective positions, whereas the mating coupling means for locking the shield to the hub preferably are non-releasable to prevent reuse of the needle or inadvertent release of the shield. In case the different positions are not predefined, there may be an indefinite number of equivalent positions for each of the “functional” positions; however, the term “position” when used in the present context covers any such plurality of functionally equivalent positions.


In a preferred embodiment the housing comprises a resilient self-sealing septum mounted generally at a proximal end of the cannula for normally closing the proximal end thereof. The infusion needle being mounted there through in its initial coupled position.


In a further preferred embodiment the housing comprises a cavity having an inlet and an outlet, the outlet being in fluid communication with the cannula, the inlet being adapted for receiving the insertion needle and preferably comprises a resilient self-sealing septum as described above. The cavity may be provided with one or more additional openings providing access thereto, each opening being closed by a self-sealing septum or any other suitable closure means for sealing the opening when not in use. Indeed, in a simple configuration, the opening may be formed by the proximal end of the cannula.


All of the above features are desirably provided in an infusion set constructed from relatively simple and preferably disposable components which can be manufactured in a cost-efficient manner from medical grade plastic or the like, the needle itself preferably being made from stainless steal.





BRIEF DESCRIPTION OF THE DRAWINGS

In the following the invention will be further described with references to the drawings, wherein



FIG. 1 shows a three-dimensional representation of an infusion set in an initial position comprising an infusion device and an insertion device in accordance with the invention.



FIG. 2A shows a longitudinal cross-sectional view of the set shown in FIG. 1,



FIG. 2B shows a transverse cross-sectional view of the set shown in FIG. 1,



FIG. 3 shows a longitudinal cross-sectional view of the insertion device shown in FIG. 1,



FIG. 4A shows a three-dimensional representation of the infusion set of FIG. 1 with a shield member in a retracted position,



FIG. 4B shows the infusion set of FIG. 4A in a side view,



FIG. 5A shows a three-dimensional representation of the insertion device of FIG. 3 with the shield member in a final position,



FIG. 5B shows the insertion device of FIG. 5A in a side view,



FIG. 5C shows a longitudinal cross-sectional view of the insertion device of FIG. 5A,



FIG. 6 shows a schematic representation of a further embodiment an infusion set in an initial position,



FIG. 7 shows the infusion set of FIG. 6 with the shield member in a retracted position, and



FIG. 8 shows the insertion device of FIG. 6 with the shield member in a final position





DESCRIPTION OF THE PREFERRED EMBODIMENTS


FIG. 1 shows a preferred embodiment of the invention comprising two individual components, an infusion device 100 comprising a housing 110 and a cannula 150, and an insertion device 200 releasably coupled thereto and comprising a hub 210 and a hollow needle 250 mounted thereon, the needle being adapted to extend through the cannula and beyond the outer tip thereof when the insertion device as shown is connected to the housing, the insertion device further comprising a shield member 230 for shielding the tip of the needle. In the shown embodiment the housing comprises a cap 132 arranged in an inlet opening in the housing (to be explained in greater detail below).


The housing 110 generally has a disc-formed, circular configuration (see FIGS. 2A and 2B) defining an upper surface 111, a lower surface 112 defining a general plane for the housing as well as for the infusion set in general, a front end and a rear end, and has a central bore formed there through, the bore having a rear portion forming a cavity 115 with an opening 113 and a front portion 116 of reduced diameter. In the following these orientations will generally be used for all components and structures.


The cannula 150 comprises a straight tubular main portion 152 forming the cannula per se and having an outer tip 151 with a distal opening, and a rear portion 153 adapted to be sealingly received and mounted coaxially in the front-most portion of the bore, thereby defining an outlet from the cavity. In the rear-most portion of the cavity a resilient self-sealing septum 120 is mounted generally axially in respect of the cannula and defining an inlet for the cavity, this allowing an infusion needle to be mounted through the septum and out through the cannula. As appears, the cannula and the central bore are arranged slightly inclined with respect to the general plane of the housing, this for facilitating mounting of the infusion device on the skin surface of a user.


In the shown embodiment the housing comprises a further bore 130 in communication with the central bore and arranged perpendicularly thereto, the further bore comprising a further resilient self-sealing septum 131 defining a further inlet for the cavity, the septum being protected by a releasably mounted semi-circular cap 132, however, in order to allow a standard tube connector to be connected, the septum may be dispensed with. Optionally the housing may be provided with a peripheral cover member 118 to improve grip and appearance.


The hub 210 comprises a mounting portion 211 to which the needle 250 is fixedly mounted, two laterally arranged handle portions 212, 213 providing gripping surfaces for handling the device, an upwardly open groove 214 being defined therebetween and extending coaxially with the needle, and a forwardly protruding “bridge” portion 215 extending as a continuation of the groove. As appears, a transverse slot or opening 216 having front and rear edges 217, 218 is provided in the bridge portion as well as coupling means 219 is associated with groove, the importance of which will be described in detail below.


The shield member comprises a generally flat roof-like cover portion 231 having lateral edges 236, 237 and a rounded nose portion 232 at the distal end thereof adapted to substantially surround the pointed needle tip 251, and a rearwardly protruding “bridge” portion 233 pivotably attached to the bridge portion of the hub, thereby defining a hinge 235 which in the shown embodiment is in the form of a film-hinge. As appears, the bridge portions span across the upper surface of the housing thereby connecting the hub with the shield member. Indeed, functionally the bridge may be formed as a single portion, the hinge being arranged corresponding to a rear or front portion of the housing, or it may be provided by lateral members arranged along the sides of the housing, or in any other suitable way.


Protruding downwardly from the proximal portion of the cover are arranged coupling arms 240 formed with coupling means adapted to engage corresponding mating coupling means on the housing. The coupling means may be in the form of distal hook members arranged on the arms gripping edge portions on the housing, or the arms may be slightly inwardly curved as shown. In FIG. 3 the insertion device is shown detached from the housing.


In FIGS. 1, 2A and 2B the infusion set is shown in its initial state as supplied to the user, i.e, with the needle mounted through the cavity and with the pointed tip protruding from the distal opening of the cannula, and with the shield member arranged generally coaxially with the cannula/needle, the nose portion 232 substantially surrounding the needle tip. Due to the coupling arms 240 the shield member as well as the insertion device as such is locked in piece to the housing


Next, use of the device in accordance with the invention will be described. In order to insert the cannula with the needle arranged there through, the shield member 230 is pivoted upwardly and backwardly approximately 180 degrees as shown in FIGS. 4A and 4B, thereby positioning the shield member in the retracted position allowing the cannula to be inserted. In the shown embodiment the shield member is positioned and locked in place in the groove 214 formed in the hub, the coupling means 219 associated with groove gripping the lateral edges 236, 237 of the shield thereby holding it releasably in place, this providing for improved handling during the insertion procedures.


In the shown embodiment no special locking means is provided between the hub and the housing, the components being coupled to each by the frictional engagement between the needle and the septum respectively the inside of the cannula. In case the resistance to penetration by the needle is high, the user will grip the infusion set to gently press the components together corresponding to the longitudinal axis of the cannula. If deemed necessary, a releasable locking means may be provided between the hub and the housing.


In order to indicate that the needle tip has been positioned in a blood vessel, the proximal end of the needle may be in fluid communication with a ventilated so-called flash chamber (not shown) which is adapted to be filled with blood a transparent window allowing this to be observed by the user. Indeed, in case the cannula is intended for being placed at a selected subcutaneous site, such a chamber would not be relevant.


When the needle tip has been positioned properly, e.g. at a selected subcutaneous site or in a blood vessel, the insertion device and thus the needle is retracted from the cannula and the housing. The lower surface of the housing may be provided with an adhesive allowing it to be attached to the skin surface of the user, or it may be held in place by additional adhesive means. After this, a fluid source may be connected to any of the fluid inlets to the cavity for supplying a fluid out through the cannula.


When the insertion device has been withdrawn from the infusion device, the shield member is disengaged from the groove and pivoted to a final position at least covering the needle. In the shown embodiment the shield member is pivoted further downwardly and subsequently upwardly until engagement with a lower surface of the hub thereby bending the needle as shown in FIGS. 5A–5C As appears, the shield member is thereby pivoted approximately 315 degrees (⅞ of a full turn) from the retracted position to the final position. In order to properly secure the shield member in its final position, the coupling arms 240 are formed with coupling means adapted to engage corresponding mating coupling means associated with the slot 216 when placed there through. The coupling means may be in the form of distal hook members on the arms adapted to engage a sharp edge on the front edge 218, or the arms may be gripped by both of the front and rear edge 217, 218. As appears, by this arrangement the coupling means on the shield member may be used with corresponding coupling means on both the housing and the hub. To prevent inadvertent release of the shield, the coupling means between the shield member and the hub should to a high degree be “non-releasable”, i.e. to function as locking means.


As the needle is bend when the shield member and the hub is locked together, the bend needle provides a biasing effect between the locking means and assures that the bend needle closely abuts on the shield to further ensure that unintended contact with the needle is avoided.


With reference to FIGS. 6–8 a second preferred embodiment will be described, the second embodiment generally having a configuration corresponding to the first embodiment


More specifically, FIG. 6 shows an infusion set comprising two individual components, an infusion device 300 comprising a disc formed housing 310 (defining a general plane for the infusion set) and a cannula 350, and an insertion device 400 releasably coupled thereto and comprising a hub 410 and a hollow needle 450 mounted thereon, the needle being adapted to extend through the cannula and beyond the outer tip thereof when the insertion device as shown is connected to the housing, the insertion device further comprising a shield member 430 for shielding the tip of the needle. Whereas the first embodiment was provided with a hinge 235 allowing the shield member to pivot corresponding to a “well-defined” axis parallel with the general plane of the infusion device, the second embodiment is provided with a flexible hinge member 435 in the form of a zigzag portion allowing the shield member to deflect to either side, i.e. in the general plane of the infusion device. Mating coupling means are provided on the shield member respectively the hub for releasably locking the shield member in the retracted position, respectively for locking the shield member in the final position in which the shield covers the needle when the insertion device has been removed from the housing.


Next, use of the device corresponding to the second embodiment will be described. In order to insert the cannula with the needle arranged there through, the shield member 430 is pivoted backwardly towards the hub 410 approximately 160 degrees as shown in FIG. 7, thereby positioning the shield member in the retracted position allowing the cannula to be inserted, see FIG. 7. As appears, the shield member pivots corresponding to a first hinge member 436 of the zigzag portion. As shown, the shield member is positioned and locked in place along a side portion of the hub by a flange 431 being gripped by a corresponding slot (not shown) in the hub thereby holding it releasably in place, this providing for improved handling during the insertion procedures.


After the cannula has been placed, the insertion device is withdrawn from the infusion device and the shield member is disengaged from the hub and “pivoted” to a final position covering the needle, see FIG. 8. As appears, the shield member first pivots corresponding to the first hinge member 436 of the zigzag portion and thereafter corresponding to a second hinge member 437, whereby the shield member is “pivoted” approximately ⅞ of a full turn from the retracted position to the final position. Indeed, in a factual situation of use, both hinge members will participate when the shield member is pivoted to either side. In order to properly secure the shield member in its final position, the hub is formed with coupling means 411 adapted to engage corresponding mating coupling means (not shown) on the shield member. To prevent inadvertent release of the shield, the coupling means between the shield member and the hub should to a high degree be “non-releasable”, i.e. to function as locking means


As in the first embodiment, the needle is bend when the shield member and the hub is locked together, the bend needle providing a biasing effect between the locking means.


While the present invention has been described in connection with the preferred embodiment shown in the various figures, it is to be understood that other similar embodiments may be used or modifications and additions may be made to the described embodiment for performing the same function of the present invention without deviating there from. For example, the shield may be provided by two or more members connected to each other, just as the means allowing the shield member to move between the different positions relative to the hub may be provided by e.g. a telescoping arrangement instead of one or more hinges.


Therefore, the present invention should not be limited to any single embodiment, but rather construed in accordance with the appended claims.

Claims
  • 1. An infusion set comprising: an infusion device having a housing comprising an opening and a soft cannula extending from the housing and being in flow communication with the opening, the soft cannula having an outer tip,an insertion device adapted to be releasably connected to the housing, the insertion device comprising a hub and a needle mounted thereon, the needle being adapted to extend through the opening and beyond the outer tip of the cannula when the insertion device is connected to the housing, the needle being at the outer end adapted for facilitating puncturing,wherein the insertion device further comprises a shield member pivotally connected to said hub, and having at least one first position in which it covers the cannula and the protruding outer tip of the needle when the insertion device is connected to the housing, at least one second position allowing the cannula to be inserted into the body of a patient when the insertion device is connected to the housing, said shield member being movable upon removal of said insertion device from said housing to at least one third position in which said shield member covers the needle and the outer tip thereof.
  • 2. An infusion set as defined in claim 1, wherein the hub and the shield member in combination provides a bridging means spanning the housing from a rear to a front portion thereof.
  • 3. An infusion set as defined in claim 1, wherein the housing comprises a cavity having a rear end with an opening, and an opposed front end in fluid communication with the cannula, the needle being mounted through the opening and out through the cannula, the opening preferably comprising a self-sealing penetratable septum allowing the needle to be mounted there through.
  • 4. An infusion set as defined in claim 1, wherein the housing has a generally flat configuration with a lower surface adapted to engage a skin surface of a user and an opposed upper surface, the insertion device comprising a bridge portion spanning the upper surface, the bridge portion comprising a hinge member allowing the shield member to pivot relative to the hub.
  • 5. An infusion set as defined in claim 1, wherein the housing has a lower surface adapted to engage a skin surface of a user and defining a general plane for the infusion set, the shield member being arranged to pivot relative to the hub corresponding to an axis in parallel with or perpendicular to the general plane.
  • 6. An infusion set comprising: an infusion device having a housing comprising an opening and a soft cannula extending from the housing and being in flow communication with the opening, the soft cannula having an outer tip,an insertion device adapted to be releasably connected to the housing, the insertion device comprising a hub and a needle mounted thereon, the needle being adapted to extend through the opening and beyond the outer tip of the cannula when the insertion device is connected to the housing, the needle being at the outer end adapted for facilitating puncturing,wherein the insertion device further comprises a shield member pivotally connected to said hub, and having a position in which it covers the cannula and the protruding outer tip of the needle when the insertion device is connected to the housing, a position allowing the cannula to be inserted into the body of a patient when the insertion device is connected to the housing, said shield member being movable upon removal of said insertion device from said housing to a position in which said shield member covers the needle and the outer tip thereof,wherein mating coupling means are provided on the shield member and the housing for releasably locking the shield member in an initial position in which it covers the cannula and the protruding outer tip of the needle when the insertion device is connected to the housing.
  • 7. An infusion set comprising: an infusion device having a housing comprising an opening and a soft cannula extending from the housing and being in flow communication with the opening, the soft cannula having an outer tip,an insertion device adapted to be releasably connected to the housing, the insertion device comprising a hub and a needle mounted thereon, the needle being adapted to extend through the opening and beyond the outer tip of the cannula when the insertion device is connected to the housing, the needle being at the outer end adapted for facilitating puncturing,wherein the insertion device further comprises a shield member pivotally connected to said hub, and having a position in which it covers the cannula and the protruding outer tip of the needle when the insertion device is connected to the housing, a position allowing the cannula to be inserted into the body of a patient when the insertion device is connected to the housing, said shield member being movable upon removal of said insertion device from said housing to a position in which said shield member covers the needle and the outer tip thereof,wherein mating coupling means are provided on the shield member and the hub for locking said shield member in said position in which the shield member covers the needle when the insertion device has been removed from the housing.
  • 8. An infusion set as defined in claim 7, wherein the needle is bent when the shield member and the hub are locked together, whereby the bent needle provides a biasing effect between cooperating locking means on the shield part and the handle part, and whereby the bent needle closely abuts on the shield.
Priority Claims (1)
Number Date Country Kind
2002 00208 Feb 2002 DK national
US Referenced Citations (352)
Number Name Date Kind
643544 Simmons Feb 1900 A
1838825 Goldstein Dec 1931 A
1991103 King Feb 1935 A
2047010 Dickinson Jul 1936 A
2295849 Kayden Sep 1942 A
2319731 Garrett May 1943 A
2533731 Gomberg Dec 1950 A
2630803 Baran Mar 1953 A
2690529 Lindblad Sep 1954 A
2730099 Sullivan Jan 1956 A
2839060 Ormo Jun 1958 A
2936141 Rapata May 1960 A
2952420 Von Hoom Sep 1960 A
3055361 Ballard Sep 1962 A
3107785 Roehr Oct 1963 A
3074541 Roehr Nov 1963 A
3154080 Rowan et al. Oct 1964 A
3317166 Janssen May 1967 A
3545286 Stenstrom Dec 1970 A
3610240 Harautuneian Oct 1971 A
3648999 Bauer Mar 1972 A
3783996 Gerard et al. Jan 1974 A
3831729 Howard May 1974 A
3814097 Ganderton et al. Jun 1974 A
3840011 Wright Oct 1974 A
3865236 Rycroft Feb 1975 A
3942528 Loeser Mar 1976 A
3986508 Barrington Oct 1976 A
4014328 Cluff et al. Mar 1977 A
4022205 Tenczar May 1977 A
4146113 Gavel Mar 1979 A
4150798 Aragon Apr 1979 A
4188950 Wardlaw Feb 1980 A
4201406 Dennehey et al. May 1980 A
4227528 Wardlaw Oct 1980 A
4267836 Whitney et al. May 1981 A
4306705 Svenson Dec 1981 A
4315505 Crandall et al. Feb 1982 A
4334551 Pfister Jun 1982 A
D267199 Koenig Dec 1982 S
4365630 McFarlane Dec 1982 A
4400861 Parker Aug 1983 A
4406042 McPhee Sep 1983 A
4458344 Coogler Jul 1984 A
4472024 Konomura et al. Sep 1984 A
4473369 Lueders et al. Sep 1984 A
4500312 McFarlane Feb 1985 A
4517971 Sorbonne May 1985 A
4530695 Phillips et al. Jul 1985 A
4531686 Shaw Jul 1985 A
4576846 Noel Mar 1986 A
4606735 Wilder et al. Aug 1986 A
4610469 Wolff-Mooij Sep 1986 A
4616790 Beltran Oct 1986 A
4619349 Braun Oct 1986 A
4635683 Nielsen Jan 1987 A
4637404 Gessman Jan 1987 A
4662873 Lash et al. May 1987 A
4682702 Gach Jul 1987 A
4713059 Bickelhaupt et al. Dec 1987 A
4734092 Millerd Mar 1988 A
4755173 Konopka et al. Jul 1988 A
4758020 Boyd Jul 1988 A
4800629 Ikeda Jan 1989 A
4802638 Burger et al. Feb 1989 A
4817603 Turner et al. Apr 1989 A
RE32922 Levin et al. May 1989 E
4838871 Luther Jun 1989 A
4840613 Balbierz Jun 1989 A
4850974 Bickelhaupt et al. Jul 1989 A
4878897 Katzin Nov 1989 A
4895570 Larkin Jan 1990 A
D306500 Brahler Mar 1990 S
4913369 Lia et al. Apr 1990 A
4917669 Bonaldo Apr 1990 A
4935010 Cox et al. Jun 1990 A
4950163 Zimble Aug 1990 A
4950252 Luther et al. Aug 1990 A
4978338 Melsky et al. Dec 1990 A
4982842 Hollister Jan 1991 A
4986817 Code Jan 1991 A
4994045 Ranford Feb 1991 A
5011475 Olson Apr 1991 A
5024662 Menes et al. Jun 1991 A
5067496 Eisele Nov 1991 A
5077872 Guthammar Jan 1992 A
5083757 Barsky Jan 1992 A
5098389 Cappucci Mar 1992 A
5112313 Sallee May 1992 A
5116319 van den Haak May 1992 A
5116324 Bierley et al. May 1992 A
5116325 Paterson May 1992 A
5121751 Panalletta Jun 1992 A
5134593 Logan et al. Jul 1992 A
5134594 Woo Jul 1992 A
5137524 Lynn et al. Aug 1992 A
5141496 Dalto et al. Aug 1992 A
5147319 Ishikawa et al. Sep 1992 A
5147375 Sullivan et al. Sep 1992 A
5161681 Kemp et al. Nov 1992 A
5163915 Holleron Nov 1992 A
5176662 Bartholomew et al. Jan 1993 A
5188314 Peters Feb 1993 A
5188611 Orgain Feb 1993 A
RE34223 Bonaldo Apr 1993 E
5222947 D'Amico Jun 1993 A
5232454 Hollister Aug 1993 A
5236143 Dragon Aug 1993 A
5240199 Peters Aug 1993 A
5248301 Koenig et al. Sep 1993 A
5256152 Marks Oct 1993 A
5257980 Van Antwerp et al. Nov 1993 A
5265822 Shober, Jr. et al. Nov 1993 A
5269799 Daniel Dec 1993 A
5279579 D'Amico Jan 1994 A
5279591 Simon Jan 1994 A
5282793 Larson Feb 1994 A
5300030 Crossman et al. Apr 1994 A
5312359 Wallace May 1994 A
5312369 Arcusin et al. May 1994 A
5316246 Scott et al. May 1994 A
5324302 Crouse Jun 1994 A
5342319 Watson et al. Aug 1994 A
5342324 Tucker Aug 1994 A
5343637 Schindler Sep 1994 A
5350392 Purcell et al. Sep 1994 A
5354280 Haber et al. Oct 1994 A
5366469 Steg et al. Nov 1994 A
5372592 Gambale Dec 1994 A
5376082 Phelps Dec 1994 A
5380067 Turvill et al. Jan 1995 A
5384174 Ward et al. Jan 1995 A
5387197 Smith et al. Feb 1995 A
5388931 Carlson Feb 1995 A
5390669 Stuart et al. Feb 1995 A
5391151 Wilmot Feb 1995 A
5403288 Stanners Apr 1995 A
5405332 Opalek Apr 1995 A
5429607 McPhee Jul 1995 A
5429613 D'Amico Jul 1995 A
5433307 Jeppe Jul 1995 A
D362718 Deily et al. Sep 1995 S
5449349 Sallee et al. Sep 1995 A
5487506 Drummond et al. Jan 1996 A
5490841 Landis Feb 1996 A
5492313 Pan et al. Feb 1996 A
5505709 Funderburk et al. Apr 1996 A
5507730 Haber et al. Apr 1996 A
5519167 Kunimoto et al. May 1996 A
5520654 Wahlberg May 1996 A
5522803 Teissen-Simony Jun 1996 A
5533974 Gaba Jul 1996 A
5540709 Ramel Jul 1996 A
5545143 Fischell Aug 1996 A
5545152 Funderburk et al. Aug 1996 A
5554130 McDonald et al. Sep 1996 A
5558650 McPhee Sep 1996 A
5562636 Utterberg Oct 1996 A
5584813 Livingston et al. Dec 1996 A
5591188 Waisman Jan 1997 A
5599309 Marshall et al. Feb 1997 A
5599315 McPhee Feb 1997 A
5599318 Sweeney et al. Feb 1997 A
5628765 Morita May 1997 A
5643214 Marshall Jul 1997 A
5643216 White Jul 1997 A
5643220 Cosme Jul 1997 A
5662617 Odell et al. Sep 1997 A
5665071 Wyrick Sep 1997 A
5665075 Gyure et al. Sep 1997 A
5681323 Arick Oct 1997 A
5695476 Harris Dec 1997 A
5704920 Gyure Jan 1998 A
5709516 Peterson et al. Jan 1998 A
5714225 Hansen et al. Feb 1998 A
5741288 Rife Apr 1998 A
5752923 Terwilliger May 1998 A
5810835 Ryan et al. Sep 1998 A
5820598 Gazza et al. Oct 1998 A
D402538 Wagter et al. Dec 1998 S
5843001 Goldenberg Dec 1998 A
5851197 Marano et al. Dec 1998 A
5858001 Tsals et al. Jan 1999 A
5865806 Howell Feb 1999 A
5873540 Hardin Feb 1999 A
5899886 Cosme May 1999 A
5913846 Szabo Jun 1999 A
5915640 Wagter et al. Jun 1999 A
5919167 Mulhauser et al. Jul 1999 A
5925032 Clements Jul 1999 A
5947935 Rhinehart et al. Sep 1999 A
5951523 Osterlind et al. Sep 1999 A
5954643 VanAntwerp et al. Sep 1999 A
5957892 Thorne Sep 1999 A
5968011 Larsen et al. Oct 1999 A
5975120 Novosel Nov 1999 A
5980488 Thorne Nov 1999 A
5980506 Mathiasen Nov 1999 A
5984640 Wang Nov 1999 A
5984897 Peterson et al. Nov 1999 A
5992787 Burke Nov 1999 A
D417733 Howell et al. Dec 1999 S
6017328 Fischell et al. Jan 2000 A
D421119 Musgrave et al. Feb 2000 S
6039629 Mitchell Mar 2000 A
6042570 Bell et al. Mar 2000 A
6045533 Kriesel et al. Apr 2000 A
6050976 Thorne et al. Apr 2000 A
6056718 Funderburk et al. May 2000 A
6074371 Fischell Jun 2000 A
6086008 Gray et al. Jul 2000 A
6086575 Mejslov Jul 2000 A
6090068 Chanut Jul 2000 A
6093172 Funderburk et al. Jul 2000 A
6093179 O'Hara et al. Jul 2000 A
6099503 Stardella Aug 2000 A
6105218 Reekie Aug 2000 A
6120482 Szabo Sep 2000 A
6123690 Mejslov Sep 2000 A
6132755 Eicher et al. Oct 2000 A
6183464 Sharp et al. Feb 2001 B1
6193694 Bell et al. Feb 2001 B1
6219574 Cormier et al. Apr 2001 B1
6221058 Kao et al. Apr 2001 B1
6248093 Moberg Jun 2001 B1
6293925 Safabash et al. Sep 2001 B1
6302866 Marggi Oct 2001 B1
6319232 Kashmer Nov 2001 B1
6322535 Hitchins et al. Nov 2001 B1
6322808 Trautman et al. Nov 2001 B1
6334856 Allen et al. Jan 2002 B1
6355021 Nielsen et al. Mar 2002 B1
6379335 Rigon et al. Apr 2002 B1
D456692 Epstein May 2002 S
6387076 Landuyt May 2002 B1
6488663 Steg Dec 2002 B1
6517517 Farrugia et al. Feb 2003 B1
6520938 Funderburk et al. Feb 2003 B1
D472316 Douglas et al. Mar 2003 S
D472630 Douglas et al. Apr 2003 S
6572586 Wojcik Jun 2003 B1
6579267 Lynch et al. Jun 2003 B1
6582397 Alesi et al. Jun 2003 B1
6595962 Perthu Jul 2003 B1
6607509 Bobroff et al. Aug 2003 B1
6607511 Halseth et al. Aug 2003 B1
6629949 Douglas Oct 2003 B1
6645182 Szabo Nov 2003 B1
6685674 Douglas et al. Feb 2004 B1
6702779 Connelly et al. Mar 2004 B1
6726649 Swenson et al. Apr 2004 B1
6736797 Larsen et al. May 2004 B1
6749589 Douglas et al. Jun 2004 B1
6790199 Gianakos Sep 2004 B1
6805686 Fathallah et al. Oct 2004 B1
6811545 Vaillancourt Nov 2004 B1
6814720 Olsen et al. Nov 2004 B1
6824530 Wagner et al. Nov 2004 B1
6824531 Zecha, Jr. et al. Nov 2004 B1
6830562 Mogensen et al. Dec 2004 B1
6837877 Zurcher Jan 2005 B1
6840922 Nielsen et al. Jan 2005 B1
6880701 Bergeron et al. Apr 2005 B1
6916017 Noe Jul 2005 B1
6923791 Douglas Aug 2005 B1
6926694 Marano-Ford et al. Aug 2005 B1
6939331 Ohshima Sep 2005 B1
6949084 Marggi et al. Sep 2005 B1
20010004970 Hollister et al. Jun 2001 A1
20010016714 Bell et al. Aug 2001 A1
20010021827 Ferguson et al. Sep 2001 A1
20010039401 Ferguson et al. Nov 2001 A1
20010041875 Higuchi et al. Nov 2001 A1
20020022855 Bobroff et al. Feb 2002 A1
20050101933 Marrs et al. May 2002 A1
20020068904 Pluth et al. Jun 2002 A1
20020072720 Hague et al. Jun 2002 A1
20020077599 Wojcik Jun 2002 A1
20020107489 Lee Aug 2002 A1
20020111581 Sasso Aug 2002 A1
20020145073 Swanson et al. Oct 2002 A1
20020156424 Suzuki et al. Oct 2002 A1
20020156427 Suzuki et al. Oct 2002 A1
20020161332 Ramey Oct 2002 A1
20020169419 Steg Nov 2002 A1
20020173748 McConnell et al. Nov 2002 A1
20020183688 Lastovich et al. Dec 2002 A1
20020189688 Roorda Dec 2002 A1
20020193737 Popovsky Dec 2002 A1
20020193744 Alesi et al. Dec 2002 A1
20030069548 Connelly et al. Apr 2003 A1
20030105430 Lavi et al. Jun 2003 A1
20030109829 Mogensen et al. Jun 2003 A1
20030125669 Safabash et al. Jul 2003 A1
20030125678 Swenson et al. Jul 2003 A1
20030130619 Safabash et al. Jul 2003 A1
20030139704 Lin Jul 2003 A1
20030158520 Safabash et al. Aug 2003 A1
20030176843 Wilkinson Sep 2003 A1
20030181863 Davis et al. Sep 2003 A1
20030181868 Swenson Sep 2003 A1
20030181873 Swenson Sep 2003 A1
20030181874 Bressler et al. Sep 2003 A1
20030187394 Wilkinson et al. Oct 2003 A1
20030187395 Wilkinson et al. Oct 2003 A1
20030199823 Bobroff et al. Oct 2003 A1
20030216686 Lynch et al. Nov 2003 A1
20030225373 Bobroff et al. Dec 2003 A1
20030225374 Mathiasen Dec 2003 A1
20030229308 Tsals et al. Dec 2003 A1
20030229316 Hwang et al. Dec 2003 A1
20040002682 Kovelman et al. Jan 2004 A1
20040006316 Patton Jan 2004 A1
20040026840 Eckel et al. Feb 2004 A1
20040044306 Lynch et al. Mar 2004 A1
20040049159 Barrus et al. Mar 2004 A1
20040068231 Blondeau Apr 2004 A1
20040087913 Rogers et al. May 2004 A1
20040111068 Swenson Jun 2004 A1
20040112781 Hofverberg et al. Jun 2004 A1
20040116865 Bengtsson Jun 2004 A1
20040138612 Shermer et al. Jul 2004 A1
20040138620 Douglas et al. Jul 2004 A1
20040143216 Douglas et al. Jul 2004 A1
20040143218 Das Jul 2004 A1
20040158202 Jensen Aug 2004 A1
20040158207 Hunn et al. Aug 2004 A1
20040162518 Connelly et al. Aug 2004 A1
20040171989 Horner et al. Sep 2004 A1
20040178098 Swenson et al. Sep 2004 A1
20040186446 Ohshima Sep 2004 A1
20040199123 Nielsen Oct 2004 A1
20040204687 Mogensen et al. Oct 2004 A1
20040204690 Yashiro et al. Oct 2004 A1
20040220528 Garcia, Jr. Nov 2004 A1
20040238392 Peterson et al. Dec 2004 A1
20040243065 McConnell et al. Dec 2004 A1
20040254433 Bandis et al. Dec 2004 A1
20040260235 Douglas Dec 2004 A1
20040260250 Harris et al. Dec 2004 A1
20050035014 Cane Feb 2005 A1
20050101932 Cote et al. May 2005 A1
20050107743 Fangrow, Jr. May 2005 A1
20050113761 Faust et al. May 2005 A1
20050119637 Lundgren et al. Jun 2005 A1
20050124936 Mogensen et al. Jun 2005 A1
20050159709 Wilkinson Jul 2005 A1
20050215979 Konerup et al. Sep 2005 A1
20050251098 Wyss et al. Nov 2005 A1
20050277892 Chen Dec 2005 A1
20050283114 Bresina et al. Dec 2005 A1
20060030815 Csincsura et al. Feb 2006 A1
Foreign Referenced Citations (95)
Number Date Country
893 296 Dec 1953 DE
1 053 541 Mar 1959 DE
26 20 009 Dec 1977 DE
28 03 509 Aug 1978 DE
37 15 965 Jan 1988 DE
196 31 921 Mar 1997 DE
298 18 311 Mar 1999 DE
19847143 Jan 2000 DE
299 24 406 Jan 2001 DE
101 06 074 Jun 2002 DE
37 22 893 Jun 1988 DK
38 23 447 Feb 1996 DK
196 10 692 Sep 1997 DK
198 47 143 Jan 2000 DK
100 49 001 Apr 2002 DK
0 188 014 Oct 1985 EP
0 239 244 Feb 1987 EP
0 298 521 Sep 1990 EP
0 184 231 Jan 1992 EP
0 475 857 Mar 1992 EP
0 544 837 Jun 1993 EP
0 633 039 Jul 1994 EP
0 651 662 May 1995 EP
0 714 631 Jun 1996 EP
744 183 Nov 1996 EP
0 747 006 Dec 1996 EP
0 688 232 Dec 1998 EP
0 884 108 Dec 1998 EP
0 916 361 May 1999 EP
0 931 560 Jul 1999 EP
0 956 879 Nov 1999 EP
1 045 145 Oct 2000 EP
1 060 757 Dec 2000 EP
1 086 718 Mar 2001 EP
1 125 593 Aug 2001 EP
1 167 765 Jan 2002 EP
0 775 501 Jun 2002 EP
0 894 216 Jul 2003 EP
1 380 315 Jan 2004 EP
0 956 879 Jul 2004 EP
576 849 Aug 1924 FR
2 611 013 Aug 1988 FR
2725902 Oct 1994 FR
2 733 915 Nov 1996 FR
2733915 Nov 1996 FR
2 781 617 Jan 2000 FR
2781617 Jan 2000 FR
478803 Jan 1938 GB
591730 Mar 1946 GB
906574 Sep 1962 GB
1 268 575 Mar 1972 GB
1 403 034 Aug 1975 GB
2 224 808 May 1990 GB
2 270 552 Mar 1994 GB
05326062 Dec 1993 JP
5326062 Dec 1993 JP
7051251 Nov 1995 JP
9217584 Sep 1997 JP
2000-59877 Feb 2000 JP
3140740 Feb 2000 JP
2000059877 Feb 2000 JP
3140740 Mar 2001 JP
2002-028246 Jan 2002 JP
1017427 Nov 2002 NL
WO 8706474 Nov 1987 WO
WO 9303787 Mar 1993 WO
WO 9305840 Apr 1993 WO
WO 9420160 Sep 1994 WO
WO 9528327 Oct 1995 WO
WO 9635472 Nov 1996 WO
WO 9809065 Mar 1998 WO
WO 9858693 Dec 1998 WO
WO 9907435 Feb 1999 WO
WO 9933504 Jul 1999 WO
WO 9936009 Jul 1999 WO
WO 9956802 Nov 1999 WO
WO 9961815 Dec 1999 WO
WO 0002614 Jan 2000 WO
WO 0003757 Jan 2000 WO
WO 0044324 Aug 2000 WO
WO 0104507 Jan 2001 WO
WO 0130419 May 2001 WO
WO 0168180 Sep 2001 WO
WO 0181785 Nov 2001 WO
WO 0193926 Dec 2001 WO
WO 0246080 Jun 2002 WO
WO 02066854 Aug 2002 WO
WO 02094352 Nov 2002 WO
WO 02100457 Dec 2002 WO
WO 02068014 Jan 2003 WO
WO 03015861 Feb 2003 WO
WO 03026728 Apr 2003 WO
WO 04030726 Apr 2004 WO
WO 04087240 Oct 2004 WO
WO 05004973 Jan 2005 WO
Related Publications (1)
Number Date Country
20030225374 A1 Dec 2003 US